These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19016848)

  • 1. Invasion of enteropathogenic Escherichia coli into host cells through epithelial tight junctions.
    Li Q; Zhang Q; Wang C; Li N; Li J
    FEBS J; 2008 Dec; 275(23):6022-32. PubMed ID: 19016848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteropathogenic Escherichia coli changes distribution of occludin and ZO-1 in tight junction membrane microdomains in vivo.
    Zhang Q; Li Q; Wang C; Liu X; Li N; Li J
    Microb Pathog; 2010 Jan; 48(1):28-34. PubMed ID: 19833191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cells.
    Muza-Moons MM; Schneeberger EE; Hecht GA
    Cell Microbiol; 2004 Aug; 6(8):783-93. PubMed ID: 15236645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspases-3, -8, and -9 are required for induction of epithelial cell apoptosis by enteropathogenic E. coli but are dispensable for increased paracellular permeability.
    Flynn AN; Buret AG
    Microb Pathog; 2008 Apr; 44(4):311-9. PubMed ID: 18054197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair.
    Zyrek AA; Cichon C; Helms S; Enders C; Sonnenborn U; Schmidt MA
    Cell Microbiol; 2007 Mar; 9(3):804-16. PubMed ID: 17087734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia albertii and Hafnia alvei are candidate enteric pathogens with divergent effects on intercellular tight junctions.
    Donato KA; Zareie M; Jassem AN; Jandu N; Alingary N; Carusone SC; Johnson-Henry KC; Sherman PM
    Microb Pathog; 2008; 45(5-6):377-85. PubMed ID: 18930803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cells.
    Li N; Gu L; Qu L; Gong J; Li Q; Zhu W; Li J
    Eur J Pharm Sci; 2010 Apr; 40(1):1-8. PubMed ID: 20149867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redistribution of tight junction proteins during EPEC infection in vivo.
    Zhang Q; Li Q; Wang C; Li N; Li J
    Inflammation; 2012 Feb; 35(1):23-32. PubMed ID: 21170673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricellular Tight Junction Protein Tricellulin Is Targeted by the Enteropathogenic Escherichia coli Effector EspG1, Leading to Epithelial Barrier Disruption.
    Morampudi V; Graef FA; Stahl M; Dalwadi U; Conlin VS; Huang T; Vallance BA; Yu HB; Jacobson K
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein.
    Dean P; Kenny B
    Mol Microbiol; 2004 Nov; 54(3):665-75. PubMed ID: 15491358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis.
    Viswanathan VK; Weflen A; Koutsouris A; Roxas JL; Hecht G
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1165-70. PubMed ID: 18356531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.
    Alvarez CS; Giménez R; Cañas MA; Vera R; Díaz-Garrido N; Badia J; Baldomà L
    BMC Microbiol; 2019 Jul; 19(1):166. PubMed ID: 31315566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction.
    Li Q; Zhang Q; Wang M; Zhao S; Ma J; Luo N; Li N; Li Y; Xu G; Li J
    Clin Immunol; 2008 Jan; 126(1):67-80. PubMed ID: 17964857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.
    Thanabalasuriar A; Kim J; Gruenheid S
    Microbes Infect; 2013; 15(10-11):738-44. PubMed ID: 23747681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide.
    Everett RS; Vanhook MK; Barozzi N; Toth I; Johnson LG
    Mol Pharmacol; 2006 Feb; 69(2):492-500. PubMed ID: 16288084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteropathogenic Escherichia coli type III effectors EspG and EspG2 alter epithelial paracellular permeability.
    Matsuzawa T; Kuwae A; Abe A
    Infect Immun; 2005 Oct; 73(10):6283-9. PubMed ID: 16177299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1beta-induced disruption of barrier function in cultured human corneal epithelial cells.
    Kimura K; Teranishi S; Nishida T
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):597-603. PubMed ID: 19171646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attaching and effacing pathogen-induced tight junction disruption in vivo.
    Guttman JA; Li Y; Wickham ME; Deng W; Vogl AW; Finlay BB
    Cell Microbiol; 2006 Apr; 8(4):634-45. PubMed ID: 16548889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the destruction of tight junction by patulin treatment and increase of phosphorylation of ZO-1 in Caco-2 human colon cancer cells.
    Kawauchiya T; Takumi R; Kudo Y; Takamori A; Sasagawa T; Takahashi K; Kikuchi H
    Toxicol Lett; 2011 Aug; 205(2):196-202. PubMed ID: 21704136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specific fates of tight junction proteins in apoptotic epithelial cells.
    Bojarski C; Weiske J; Schöneberg T; Schröder W; Mankertz J; Schulzke JD; Florian P; Fromm M; Tauber R; Huber O
    J Cell Sci; 2004 Apr; 117(Pt 10):2097-107. PubMed ID: 15054114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.